55
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Impact of patient adherence on the cost-effectiveness of noninvasive tests for the initial diagnosis of Helicobacter pylori infection in the United States

, , , &
Pages 45-55 | Published online: 21 Jan 2016

References

  • CheyWDWongBCAmerican College of Gastroenterology guideline on the management of Helicobacter pylori infectionAm J Gastroenterol20071021808182517608775
  • GradYHLipsitchMAielloAESecular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparitiesAm J Epidemiol2012175545922085628
  • KustersJGvan VlietAHKuipersEJPathogenesis of Helicobacter pylori infectionClin Microbiol Rev20061944949016847081
  • PetersonWLFendrickMCaveDRPeuraDAGarabedian-RuffaloSMLaineLHelicobacter pylori-related disease: guidelines for testing and treatmentArch Intern Med20001601285129110809031
  • YuanYPadolITHuntRHPeptic ulcer disease todayNat Clin Pract Gastroenterol Hepatol20063808916456574
  • TalleyNJAmerican Gastroenterological Association medical position statement: evaluation of dyspepsiaGastroenterology20051291753175516285970
  • CheyWDFendrickAMNoninvasive Helicobacter pylori testing for the “test-and-treat” strategy: a decision analysis to assess the effect of past infection on test choiceArch Intern Med20011612129213211570943
  • ElwynGTaubertMDaviesSBrownGAllisonMPhillipsCWhich test is best for Helicobacter pylori? A cost-effectiveness model using decision analysisBr J Gen Pract20075740140317504592
  • HolmesKPFangJCJacksonBRCost-effectiveness of six strategies for Helicobacter pylori diagnosis and management in uninvestigated dyspepsia assuming a high resource intensity practice patternBMC Health Serv Res20101034421176158
  • MasucciLBlackhouseGGoereeRCost-effectiveness of the carbon-13 urea breath test for the detection of Helicobacter pylori: an economic analysisOnt Health Technol Assess Ser201313128
  • VakilNRhewDSollAOfmanJJThe cost-effectiveness of diagnostic testing strategies for Helicobacter pyloriAm J Gastroenterol2000951691169810925969
  • GisbertJPPajaresJMStool antigen test for the diagnosis of Helicobacter pylori infection: a systematic reviewHelicobacter2004934736815270750
  • CullenKPBroderickBMJayaramJFlynnBO’ConnorHJEvaluation of the Helicobacter pylori stool antigen (HpSA) test in routine clinical practice – is it patient-friendly?Ir Med J20029530530612537325
  • McNultyCAWhitingJWPatients’ attitudes to Helicobacter pylori breath and stool antigen tests compared to blood serologyJ Infect200755192217276512
  • OreLHagoelLLaviIRennertGScreening with faecal occult blood test (FOBT) for colorectal cancer: assessment of two methods that attempt to improve complianceEur J Cancer Prev20011025125611432712
  • GisbertJPPajaresJM13C-urea breath test in the diagnosis of Helicobacter pylori infection – a critical reviewAliment Pharmacol Ther2004201001101715569102
  • LoyCTIrwigLMKatelarisPHTalleyNJDo commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysisAm J Gastroenterol199691113811448651160
  • CalvetXGarcíaNLópezTGisbertJPGenéERoqueMA meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infectionAliment Pharmacol Ther20001460360910792124
  • CardenasVMMullaZDOrtizMGrahamDYIron deficiency and Helicobacter pylori infection in the United StatesAm J Epidemiol200616312713416306309
  • AriasECurtinLRWeiRAndersonRNU.S. decennial life tables for 1999–2001, United States life tablesNatl Vital Stat Rep200857136
  • NivYHazaziRHelicobacter pylori recurrence in developed and developing countries: meta-analysis of 13C-urea breath test follow-up after eradicationHelicobacter200813566118205667
  • StracciFZorziMGrazziniGColorectal cancer screening: tests, strategies, and perspectivesFront Public Health2014221025386553
  • GhanouniASmithSGHalliganSPublic preferences for colorectal cancer screening tests: a review of conjoint analysis studiesExpert Rev Med Devices20131048949923895076
  • NeumannPJCohenJTWeinsteinMCUpdating cost-effectiveness – the curious resilience of the $50,000-per-QALY thresholdN Engl J Med201437179679725162885
  • OptumInsightThe Essential RBRVS 2014: A Comprehensive Listing of RBRVS Values for CPT and HCPCS CodesEden Prairie (MN)OptumInsight2014
  • Truven Health AnalyticsRed Book2014 Available from: http://micromedex.com/redbookAccessed December 13, 2015
  • KuipersEJReview article: exploring the link between Helicobacter pylori and gastric cancerAliment Pharmacol Ther199913Suppl 131110209681
  • LaineLEstradaRTrujilloMKniggeKFennertyMBEffect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pyloriAnn Intern Med19981295475509758575
  • DaviesRCrabbeDRoderickPGoddardJRRafteryJPatelPA simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancersHealth Care Manag Sci2002524925812437272
  • AsakaMSepulvedaARSugiyamaTGrahamDYGastric cancerMobleyHLMendzGLHazellSLHelicobacter pylori: Physiology and GeneticsWashingtonAmerican Society for Microbiology Press2001
  • ChibaNvan ZantenSJSinclairPFergusonRAEscobedoSGraceETreating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trialBMJ20023241012101611976244
  • YehJMHurCKuntzKMEzzatiMGoldieSJCost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancerCancer20101162941295320564399
  • HowardKLordSJSpeerAGibsonRNPadburyRKearneyBValue of magnetic resonance cholangiopancreatography in the diagnosis of biliary abnormalities in postcholecystectomy patients: a probabilistic cost-effectiveness analysis of diagnostic strategiesInt J Technol Assess Health Care20062210911816673687
  • ErstadBLCost-effectiveness of proton pump inhibitor therapy for acute peptic ulcer-related bleedingCrit Care Med2004321277128315187506
  • YouJHTsuiKKWongRSChangGCost-effectiveness of dabigatran versus genotype-guided management of warfarin therapy for stroke prevention in patients with atrial fibrillationPLoS One20127e3964022745801
  • YabroffKRLamontEBMariottoACost of care for elderly cancer patients in the United StatesJ Natl Cancer Inst200810063064118445825
  • SlawskyKCyrPLOlchanskiNHowdenCWCost-effectiveness of diagnostic strategies for H. pylori infection in a high prevalence populationGastroenterology2011140Suppl 1S203